Related Experiment Video
Updated: Dec 26, 2025
10:35
An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
18.7K
Immunology and ovarian cancers
Wen-Ling Lee1,2,3, Peng-Hui Wang3,4,5
1Department of Medicine, Cheng-Hsin General Hospital, Taipei, Taiwan, ROC.
Journal of the Chinese Medical Association : JCMA
|March 10, 2020
Summary
Epithelial ovarian cancer (EOC) often relapses after standard treatment due to chemoresistance and immune evasion. Immunotherapy offers a promising new approach to revolutionize EOC treatment by harnessing the immune system for precise cancer control.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Standard epithelial ovarian cancer (EOC) treatment combines surgery and chemotherapy, achieving high initial remission rates.
- Despite initial success, most advanced EOC patients relapse within years due to chemoresistance and immune evasion.
- Limited treatment options necessitate novel therapeutic strategies for effective cancer control.
Purpose of the Study:
- To review the complex interaction between the immune system and epithelial ovarian cancer (EOC).
- To highlight recent advancements in EOC immunotherapy research.
- To explore novel therapeutic avenues for overcoming treatment failure in EOC.
Main Methods:
- Literature review focusing on immunotherapy in epithelial ovarian cancer.
- Analysis of immune response interactions with EOC cells.
- Examination of emerging immunotherapeutic interventions.
Main Results:
- Chemoresistance and immune evasion are significant contributors to EOC therapeutic failure.
- Targeting EOC-associated antigens, immune checkpoint blockade, and adoptive cellular therapy show potential.
- Understanding the host immune response is crucial for developing effective EOC treatments.
Conclusions:
- Immunotherapy presents a paradigm shift in EOC research and treatment.
- Targeted immunotherapies offer a profound opportunity to revolutionize EOC patient outcomes.
- Further research into immune system interactions is vital for advancing EOC therapy.
More Related Videos
Related Concept Videos
02:07Oogenesis
68.6K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:19Psychoneuroimmunology: Diabetes and Cancer
363
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
363